In a filing, Mesa Laboratories, Inc revealed its President and CEO Owens Gary M unloaded Company’s shares for reported $0.19 million on Jun 16 ’25. In the deal valued at $97.12 per share,1,939 shares were sold. As a result of this transaction, Owens Gary M now holds 45,824 shares worth roughly $3.35 million.
Then, Archbold Brian David sold 472 shares, generating $45,840 in total proceeds. Upon selling the shares at $97.12, the SVP Operations now owns 558 shares.
Before that, Sakys John sold 642 shares. Mesa Laboratories, Inc shares valued at $62,350 were divested by the CFO at a price of $97.12 per share. As a result of the transaction, Sakys John now holds 12,865 shares, worth roughly $0.94 million.
Wells Fargo upgraded its Mesa Laboratories, Inc [MLAB] rating to an Equal weight from a an Underweight in a research note published recently. A number of analysts have revised their coverage, including Wells Fargo’s analysts, who began to cover the stock in late August with a ‘”an Underweight”‘ rating. Evercore ISI also remained covering MLAB and has increased its forecast on January 04, 2024 with a “an Outperform” recommendation from previously “an In-line” rating. Evercore ISI revised its rating on January 04, 2021. It rated MLAB as “an In-line” which previously was an “an Outperform”.
Price Performance Review of MLAB
On Friday, Mesa Laboratories, Inc [NASDAQ:MLAB] saw its stock jump 5.74% to $73.14. Over the last five days, the stock has gained 18.62%. Mesa Laboratories, Inc shares have fallen nearly -40.44% since the year began. Nevertheless, the stocks have fallen -44.54% over the past one year.
How much short interest is there in Mesa Laboratories, Inc?
A steep rise in short interest was recorded in Mesa Laboratories, Inc stocks on 2025-08-29, growing by 87769.0 shares to a total of 0.4 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-31 was 0.31 million shares. There was a rise of 21.98%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on November 10, 2020 when KeyBanc Capital Markets began covering the stock and recommended ‘”a Sector weight”‘ rating along with a $287 price target.
